AI assistant
ARIX BIOSCIENCE PLC Report Publication Announcement 2021
4968_rns_2021-11-08_6f118c78-2de4-4bc5-9642-a49282c2bdb3.html
Report Publication Announcement
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
Arix Bioscience PLC (ARIX)
Arix Managing Director to Participate in Fireside Chat at the Jefferies Healthcare Conference
08-Nov-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Arix Bioscience plc
Arix Managing Director to Participate in Fireside Chat at the Jefferies Healthcare Conference
LONDON, 8 November 2021: Arix Bioscience plc ("Arix" or the "Company") (LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that Mark Chin, Managing Director, is scheduled to participate in a virtual analyst-led fireside chat with Matthew Hose, Equity Research Analyst, at Jefferies London Healthcare Conference taking place in person and virtually from 16-19 November 2021 in London.
A webcast of the fireside chat will be available on the Jefferies conference portal and the replay will be available afterwards on the Investor Relations section of Arix's website here.
ENDS
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc
+44 (0) 20 7290 1050
Optimum Strategic Communications
Mary Clark, Manel Mateus
+44 (0)20 8078 4357
About Arix Bioscience plc
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting-edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com
| ISIN: | GB00BD045071 |
| Category Code: | MSCM |
| TIDM: | ARIX |
| LEI Code: | 213800OVT3AHQCXNIX43 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 126161 |
| EQS News ID: | 1246669 |
| End of Announcement | EQS News Service |